A critical assessment of the role of pharmacogenomics and pharmacogenetics approaches to cardiovascular diseases.
Amouyel
P
P
INSERM U508, Institut Pasteur de Lille, France. philippe.amouyel@pasteur-lille.fr
D002318:Cardiovascular Diseases / Q000235:genetics*; D023281:Genomics / Q000639:trends*; D006801:Humans; D010597:Pharmacogenetics / Q000639:trends*